Holen Sie sich die Stockscreener-App
326.03
1.55%
4.965
Handel nachbörslich:
326.03
Schlusskurs vom Vortag:
$321.06
Offen:
$319.4
24-Stunden-Volumen:
378.93K
Relative Volume:
0.81
Marktkapitalisierung:
$8.79B
Einnahmen:
$2.16B
Nettoeinkommen (Verlust:
$416.39M
KGV:
24.89
EPS:
13.1
Netto-Cashflow:
$540.93M
1W Leistung:
+4.79%
1M Leistung:
+9.48%
6M Leistung:
-2.60%
1J Leistung:
-19.38%
1-Tages-Spanne:
$318.03
$328.06
1-Wochen-Bereich:
$305.69
$328.06
52-Wochen-Spanne:
$250.05
$459.77
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Vergleichen Sie MEDP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
326.03 | 8.79B | 2.16B | 416.39M | 540.93M | 13.10 |
|
TMO
Thermo Fisher Scientific Inc
|
427.76 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.50 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
542.71 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.66 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
164.65 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Medpace (MEDP) Dips More Than Broader Market: What You Should Know - Nasdaq
Is Medpace Holdings, Inc. (NASDAQ:MEDP) Trading At A 48% Discount? - simplywall.st
Medpace: An Excellent Company In A Context Of Uncertainty (NASDAQ:MEDP) - Seeking Alpha
Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
truist securities maintains hold rating on medpace stock By Investing.com - Investing.com Canada
truist securities maintains hold rating on medpace stock - Investing.com
Why Medpace Holdings Shares Are Under Pressure - TipRanks
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.
Is Medpace Stock Worth the Hype? Here's What Analysts Think. - AOL.com
Is Medpace Stock Worth The Hype? Here's What Analysts Think. - Barchart.com
Investing in Medpace Holdings (NASDAQ:MEDP) five years ago would have delivered you a 211% gain - simplywall.st
Deutsche Bank AG Sells 5,583 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - Defense World
Medpace Holdings, Inc. (MEDP): A Bull Case Theory - Insider Monkey
Hedge Funds Question Market Rally, Build Massive Short WallAmer Sports (NYSE:AS), First Solar (NASDAQ:FSLR) - Benzinga
William Blair Remains a Hold on Medpace Holdings (MEDP) - The Globe and Mail
Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Consensus Rating of “Hold” from Analysts - Defense World
Medpace Holdings Approves Key Proposals at Annual Meeting - TipRanks
RNA Therapy Clinical Trials Market Top Companies StudyCharles - openPR.com
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance
Medpace Holdings Surpasses Expectations with Q1 2025 EarningsNews and Statistics - IndexBox
MEDP STOCK ALERT: Levi & Korsinsky Notifies Medpace Holdings, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)? - Yahoo Finance
Medpace Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Investor Optimism Abounds Medpace Holdings, Inc. (NASDAQ:MEDP) But Growth Is Lacking - simplywall.st
Hsbc Holdings PLC Has $566,000 Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP) - Defense World
Medpace forecasts 2025 revenue between $2.14B and $2.24B amid funding challenges - MSN
Positive Long-Term Outlook for Narrow-Moat Medpace Despite Macroeconomic Pressure in Near Term - Morningstar
Press Release Distribution & PR Platform - ACCESS Newswire
Medpace (MEDP) Faces Earnings Volatility Amid Tariff Concerns - GuruFocus
Medpace drops despite Q1 beat amid disappointing performance metrics - MSN
William Blair Issues Negative Outlook for Medpace Earnings - Defense World
Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight - GuruFocus
William Blair Forecasts Medpace’s Q3 Earnings (NASDAQ:MEDP) - Defense World
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2025 Earnings Call Transcript - MSN
Medpace to increase size of stock buyback program by $1B - MSN
William Blair Downgrades Medpace Holdings (BMV:MEDP) - Nasdaq
Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Ho - GuruFocus
Truist Adjusts Medpace (MEDP) Price Target to $300, Maintains Hold Rating | MEDP Stock News - GuruFocus
Truist Cuts Price Target on Medpace Holdings to $300 From $333, Keeps Hold Rating - marketscreener.com
Medpace (MEDP) Price Target Reduced to $313 Amid Cautious Outloo - GuruFocus
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Medpace Holdings Inc-Aktie (MEDP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DAVENPORT FRED B JR | Director |
Apr 24 '25 |
Sale |
301.82 |
1,712 |
516,716 |
2,998 |
1.52%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):